Oxazepam (Epilepsy) - Medication and Pregnancy KB

Oxazepam (Epilepsy)

Exposed non-exposed studies (cohort)

Study	Country Study period	Population source	Exposure definition	Non-exposure definition	Sample size	Rmk
Mawer (Epilepsy) (Controls exposed to Lamotrigine, sick), 2010	United Kingdom 2000 - 2006	Midwives in the antenatal clinics approached each woman, who gave a history of epilepsy (n=231), whatever her stage of gestation.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	exposed to other treatment, sick Children born to mothers with epilepsy exposed to lamotrigine monotherapy in utero.	1 / 40	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, disease free), 2010	United Kingdom 2000 - 2006	Women with epilepsy (WWE) and the healthy woman controls attending the same clinic.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	unexposed, disease free Children born to mothers without epilepsy who attended the same clinic on the same day or a few days later.	1 / 315	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, sick), 2010	United Kingdom 2000 - 2006	Midwives in the antenatal clinics approached each woman, who gave a history of epilepsy (n=231), whatever her stage of gestation.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	unexposed, sick Children born to women with untreated epilepsy, who took no antiepileptic drugs before or during pregnancy.	1 / 46	Period of exposure confirm by author's email.

Case-control studies (cohort)

Study	Country Study period	Case	Control	Sample size	Rmk

Warning! There are no case-control studies available for this drug.

master protocol